Simcere and G1 Therapeutics Announce Exclusive License Agreement for Trilaciclib in Greater China

Simcere and Primary Peptides Launch Exclusive China Partnership

Clinical Data of Envafolimab to be Released at ASCO 2020

Simcere’s Donation for Battle Against Covid-19

Simcere, Alphamab Oncology and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China

Simcere appoints Dr. Kevin Oliver as Senior Vice President

Orencia^® (abatacept injection), the innovative drug in the field of rheumatology immunity co-developed by BMS and Simcere, is approved

Simcere and GI Innovation Announce Collaboration and Exclusive License Agreement for Immunotherapy Drugs in China

Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China

Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China